ILA — Island Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- AU$123.95m
- AU$116.70m
- AU$0.06m
Annual balance sheet for Island Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 6.46 | 4.79 | 2 | 1.66 | 7.25 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.059 | 0.021 | 0.017 | 0.891 | 0.18 |
| Prepaid Expenses | |||||
| Total Current Assets | 6.64 | 4.9 | 2.05 | 2.56 | 7.49 |
| Total Assets | 6.64 | 4.9 | 2.05 | 2.56 | 7.49 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.237 | 0.581 | 0.264 | 1.05 | 0.336 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.237 | 0.581 | 0.264 | 1.05 | 0.336 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 6.4 | 4.32 | 1.79 | 1.52 | 7.16 |
| Total Liabilities & Shareholders' Equity | 6.64 | 4.9 | 2.05 | 2.56 | 7.49 |
| Total Common Shares Outstanding |